Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
Contact
  • Home
  • /
  • Resources
  • /
  • Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

  • Category: Published research

Study to determine the ability of clinically available volumetric MRI (vMRI) and CSF biomarkers, alone or in combination with a quantitative learning measure, to predict conversion to Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI). 2011 October 12.

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
  • 3 mins

07/24/2025

Understanding the Hippocampal Occupancy Score

Cortechs.ai | Advancing Prostate MRI with Restriction Spectrum Imaging
  • 2 mins

07/16/2025

Advancing Prostate MRI with Restriction Spectrum Imaging

Why is OnQ Prostate unique, and what makes it a game-changer for clinicians?

Cortechs.ai | Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT
  • 3 mins

07/08/2025

Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT

Time-sensitive and precise diagnostic imaging can mean the difference between rapid intervention and devastating outcomes.

Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
  • 2 mins

07/07/2025

When to repeat an MRI scan for NeuroQuant®

NeuroQuant® can process an array of exams. However, there are some circumstances that will require you to repeat a scan.

,

Cortechs.ai | Understanding Microvascular Ischemic Disease and the Value of NeuroQuant Microvascular Reports
  • 6 mins

06/27/2025

Understanding Microvascular Ischemic Disease and the Value of NeuroQuant Microvascular Reports

Accurate, objective data is important in the effort to standardize reporting on vascular lesions and their associated pathologies.

Cortechs.ai | Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game
  • 3 mins

06/16/2025

Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game

PET imaging is transforming how we detect and monitor Alzheimer’s disease, enabling earlier diagnosis, better disease tracking, and more personalized treatment.

View our insights
Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top